Sunstein Insights
Back to All Publications
Strategies for Pharmaceutical Portfolio & Product Life-Cycle Management In Face of the New U.S. Patent Law
SMi Pharmaceutical Portfolio and Product Life Cycle Management Conference, London, April 2013.
Most Popular
-
Massachusetts Jury Sets New Record Under Federal Defend Trade Secrets Act With $452 Million Damages Award
-
New Trademark Office Fees Increase Cost, Headaches
-
The New York Times v. OpenAI: The Biggest IP Case Ever
-
Advertisers Beware: Falsely Advertising Products as “Patented” and “Proprietary” Can Violate the Lanham Act, Says the Federal Circuit
-
Corporate Transparency Act: To File or Not to File?
-
Wavy Baby Waves Goodbye to its Attempt at Humor
Authors
-
Steven A. Abreu
-
Robert M. Asher
-
Thomas C. Carey
-
Lawrence M. Green
-
Shane Hunter
-
Peter J. Karol
-
Kelly Kutsor
-
Christopher Lacenere, Ph.D.
-
Michele Liu Baillie
-
Sunstein
-
London K. Lundstrum
-
Kevin R. Mosier
-
John W. Powell
-
Rob D. Pyatt
-
Jackie Salwa
-
Katherine W. Soule
-
Bruce D. Sunstein
-
Kerry L. Timbers
-
Lisa M. Tittemore
We use cookies to improve your site experience, distinguish you from other users and support the marketing of our services. These cookies may store your personal information. By continuing to use our website, you agree to the storing of cookies on your device. For more information, please visit our Privacy Notice.